Related Experiment Videos
Nitinol stents: their value in tracheobronchial obstruction
M P Colreavy1, I Keogh, S Hone
1Department Of Otolaryngology/Head and Neck Reconstructive Surgery, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.
Clinical Otolaryngology and Allied Sciences
|August 16, 2000
Summary
Nitinol stents offer a promising solution for tracheobronchial obstruction, significantly improving patient symptoms with minimal airway reaction. Caution is advised for benign conditions due to their permanent nature.
Area of Science:
- Medical Engineering
- Respiratory Medicine
- Materials Science
Background:
- Recurrent tracheobronchial obstruction presents a significant clinical challenge, often with limited surgical options.
- Existing treatment modalities for airway obstruction have varying success rates and potential complications.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of a new generation of Nitinol stents for tracheobronchial obstruction.
- To assess patient outcomes and airway response following Nitinol stent insertion.
Main Methods:
- Eight Nitinol stents were implanted in six patients with malignant and benign tracheobronchial obstruction over a 12-month period.
- Clinical experience and patient symptoms were monitored post-insertion.
Main Results:
- Nearly all patients experienced dramatic symptom improvement after stent placement.
- Minimal airway reaction was observed up to 18 months post-insertion.
- Nitinol stents demonstrated significant effectiveness in managing tracheobronchial obstruction.
Conclusions:
- Nitinol stents represent a viable and effective treatment for tracheobronchial obstruction, offering substantial symptomatic relief.
- Careful consideration is necessary for benign obstructions, as Nitinol stents are considered permanent implants.
- Patient morbidity associated with the underlying condition must be carefully evaluated before treatment.